Precision Era Therapies in Asia Pacific

This report is a comprehensive analysis of the emerging Precision Era in medical therapies within the Asia Pacific region. It outlines the transformative impact of technological advancements such as genomic profiling, big data, and artificial intelligence on disease treatment and patient care. The report details the evolution of medicines towards precision therapies, which are tailored to individual patients, moving away from generic treatments. It discusses various types of precision therapies, including cell therapies, gene therapies, targeted antibody therapies, drug-device therapies, and diagnostic technologies. The report highlights the anticipated growth of these therapies, driven by ongoing research and development efforts. Additionally, it addresses the barriers to access and the necessary changes in healthcare infrastructure and funding models to fully realize the benefits of precision therapies. The document concludes with recommendations for stakeholders to facilitate the adoption of these innovative treatments, ensuring that patients can benefit from advancements in medical science.